HOME >> BIOLOGY >> NEWS
Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax

Anthrax vaccine administered in combination with a short course of antibiotics completely protected nonhuman primates from inhalational anthrax, the most lethal form of the disease, according to scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

In a collaborative study involving USAMRIID and the National Institute of Allergy and Infectious Diseases (NIAID), investigators demonstrated that postexposure vaccination can shorten the duration of antibiotic treatment required to protect against inhalational anthrax. The findings, which appear in this week's online edition of Proceedings of the National Academy of Sciences, could have important implications for public health management of anthrax bioterrorism events.

Anthrax is caused by the spore-forming bacterium Bacillus anthracis, and causes three types of disease--cutaneous, gastrointestinal, and inhalational--depending upon the route of exposure. Inhalational anthrax--the type likely to occur following a bioterrorist attack--is difficult to diagnose early, and despite antibiotic therapy, has a high fatality rate. In addition, because anthrax spores can remain in the body for extended periods, antibiotic treatment is typically recommended for 60 days or more following exposure.

As noted by the authors, following the 2001 anthrax attacks in the United States, approximately 10,000 people were offered 60 days of antibiotic therapy to prevent inhalational anthrax. Adverse events associated with this regimen--including diarrhea, nausea, vomiting, and dizziness--were commonly reported. More importantly, only about 44 percent of people completed the whole 60-day course. Thus, minimizing the duration of postexposure antibiotic treatment could be crucial to a successful defense against a large-scale anthrax attack.

In the study, two groups of rhesus macaques were exposed to very high amounts of anthrax spores by aerosol. Both groups were then given c
'"/>

Contact: Caree Vander Linden
Caree.Vanderlinden@us.army.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases
1-May-2006


Page: 1 2 3

Related biology news :

1. Vaccine trials inject hope into koalas future
2. Vaccine hope for malaria
3. Vaccine prevents prion disease in mice
4. Vaccine hope for sufferers of potentially fatal stomach bug
5. Vaccine to cope with viral diversity in HIV
6. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
7. U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication
8. Vaccine-producing plant-factories
9. HPV Vaccine: Whats next
10. Vaccine shown effective against chancroid
11. Vaccine provides 100 percent protection against avian flu virus in animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... BALTIMORE (PRWEB) , ... February 11, 2020 , ... ... has moved into The LaunchPort™ medical device accelerator in Port Covington, Baltimore. The ... the issues that must be addressed to manage increased demand for home dialysis ...
(Date:2/6/2020)... NEW YORK (PRWEB) , ... ... ... global, full-service clinical research organization (CRO) specializing in complex interventional medical device ... as Vice President, Regulatory Strategy. In this newly established role, Dorothy oversees ...
(Date:2/5/2020)... (PRWEB) , ... February 05, 2020 , ... ... developed to bring greater ease, efficiency and insight to sample processing within laboratories. ... academic and biotech laboratories conducting research in various fields, LabKey Sample Manager has ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... February 11, 2020 , ... Synagro Technologies, Inc. ... today announced that the City of Fort Worth has partnered with Synagro of ... in April of 2020, Synagro will assume operation of the city’s current biosolids ...
(Date:2/5/2020)... ... February 04, 2020 , ... Shoreline Biome , a ... strain level, has announced a new distribution partnership in Asia. , The distribution ... to companies and research organizations in China, Hong Kong, and Macau. , Gene ...
(Date:2/3/2020)... ... February 03, 2020 , ... Ovation ... Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All ... illustrates the following statistics:, Average airfare price paid ...
(Date:1/28/2020)... , ... January 28, 2020 , ... ... be the exclusive distributor to food and beverage manufactures within North America. Both ... critical suppliers. This agreement will allow each company to pool their collective resources ...
Breaking Biology Technology:
Cached News: